S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
NASDAQ:FORA

Forian (FORA) Stock Price, News & Analysis

$2.65
+0.13 (+5.16%)
(As of 04/19/2024 ET)
Today's Range
$2.47
$2.74
50-Day Range
$2.46
$3.64
52-Week Range
$1.85
$4.15
Volume
31,059 shs
Average Volume
27,028 shs
Market Capitalization
$82.50 million
P/E Ratio
8.03
Dividend Yield
N/A
Price Target
$7.67

Forian MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
189.3% Upside
$7.67 Price Target
Short Interest
Bearish
1.14% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.28mentions of Forian in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.97 out of 5 stars

Medical Sector

572nd out of 909 stocks

Health Information Services Industry

1st out of 2 stocks

FORA stock logo

About Forian Stock (NASDAQ:FORA)

Forian Inc. provides software and information solutions, proprietary data driven insights, and predictive analytics to optimize and measure the operational, clinical, and financial performance of its life science and healthcare customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides customers with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; and BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain. In addition, the company offers security monitoring and web marketing services. Forian Inc. was incorporated in 2020 and is headquartered in Newtown, Pennsylvania. Forian Inc.

FORA Stock Price History

FORA Stock News Headlines

The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
VerticalScope to Announce First Quarter 2024 Results
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
Forian Full Year 2023 Earnings: EPS Beats Expectations
Recap: Forian Q4 Earnings
Earnings Outlook For Forian
7 Growth Stocks That Could Turn $10,000 Into $500,000
See More Headlines
Receive FORA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Forian and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/20/2024
Next Earnings (Estimated)
5/10/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
Current Symbol
NASDAQ:FORA
Fax
N/A
Employees
102
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$7.67
High Stock Price Target
$13.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+189.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$20.48 million

Miscellaneous

Free Float
N/A
Market Cap
$82.50 million
Optionable
Optionable
Beta
1.03
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Michael Vesey (Age 62)
    Chief Financial Officer
    Comp: $457k
  • Mr. Edward Francis Spaniel Jr. (Age 54)
    Executive VP, General Counsel & Secretary
    Comp: $395.8k
  • Mr. Max C. Wygod (Age 36)
    Co-Founder, CEO, President & Executive Chairman of the Board
    Comp: $46.88k
  • Mr. Adam H. Dublin (Age 58)
    Co-Founder, Chief Strategy Officer & Director
    Comp: $113.7k
  • Mr. Jason Holden
    Vice President of Corporate Development
  • Rebecca Adams
    Vice President of Human Resources
  • Paul Reuscher
    Chief Commercial Officer

FORA Stock Analysis - Frequently Asked Questions

Should I buy or sell Forian stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Forian in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" FORA shares.
View FORA analyst ratings
or view top-rated stocks.

What is Forian's stock price target for 2024?

4 Wall Street analysts have issued 12 month target prices for Forian's shares. Their FORA share price targets range from $5.00 to $13.00. On average, they anticipate the company's stock price to reach $7.67 in the next year. This suggests a possible upside of 189.3% from the stock's current price.
View analysts price targets for FORA
or view top-rated stocks among Wall Street analysts.

How have FORA shares performed in 2024?

Forian's stock was trading at $2.93 at the start of the year. Since then, FORA stock has decreased by 9.6% and is now trading at $2.65.
View the best growth stocks for 2024 here
.

When is Forian's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024.
View our FORA earnings forecast
.

What guidance has Forian issued on next quarter's earnings?

Forian updated its FY 2024 earnings guidance on Thursday, March, 28th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $21.5 million-$23.6 million, compared to the consensus revenue estimate of $24.0 million.

How do I buy shares of Forian?

Shares of FORA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:FORA) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners